Anthropic's $960 Billion Pivot: Four-Day Dash from Series H to S-1
As Anthropic rushes from a $65 billion Series H to an S-1 filing in just four days, the AI fundraising window is shrinking faster than investors anticipated, signaling a new pre-IPO race.
bayareatelegraph.com
In this article
Four days. That is the interval between Anthropic closing a $65 billion Series H round at a $960 billion post-money valuation and the company confidentially submitting draft IPO paperwork to the SEC, 24/7 Wall St. reported, citing Bloomberg Businessweek's Ed Ludlow. The filing landed during the first week of June 2026, making Anthropic the first of the three great private AI labs to begin the formal process of going public, ahead of both OpenAI and SpaceX.
In any other year, a $65 billion round, the largest private fundraise in history by a wide margin, would have been the story. But the Series H was a prelude. The round itself, confirmed by Reuters, valued the Claude developer at $965 billion post-money. The number is worth pausing on. Anthropic, founded in 2021 and still deeply unprofitable by any standard accounting measure, is now worth more than the entire market capitalization of Meta Platforms at the start of 2023. The lead investor in the Series H has not been publicly named, a silence that is unusual for a round of this size. What is known is that the company moved to lock down its cap table almost immediately.
The four-day gap between a $65 billion private infusion and an S-1 filing is not a coincidence. It is a statement of intent. Anthropic's board, led by CEO Dario Amodei and president Daniela Amodei, had already signaled its posture toward secondary trading. In mid-May, the company announced that any sale or transfer of its stock without explicit board approval would be considered void, InvestmentNews reported. The ban sent a jolt through the pre-IPO secondary market, which had grown into a multi-billion-dollar shadow economy trading claims on shares of SpaceX, OpenAI, and Anthropic.
That shadow economy is the subject of a detailed Forbes investigation by Phoebe Liu, published in late May, which mapped a sprawling network of special purpose vehicles, or SPVs, broker-dealers, and platforms such as Hiive, Linqto, and Rainmaker Securities that have been funneling retail and accredited-investor capital into pre-IPO names. A cold message on LinkedIn, Forbes reported, pulled former Morgan Stanley trader Adam Crawley back from a qigong retreat in Southeast Asia into the business of sourcing allocations. The market he joined is built on a simple premise: employees and early investors hold private shares they want to monetize, and external buyers are willing to pay a premium for access to companies that may never again be available at anything resembling a reasonable price.
The premiums have become irrational in specific cases. Seeking Alpha noted in late May that publicly traded vehicles purporting to hold private SpaceX shares, such as the DestinyTech100 fund, often carry premiums to net asset value that imply a valuation far above even the reported $1.75 trillion IPO target. For Anthropic, the secondary market had been pricing shares at implied valuations north of $1 trillion before the board's crackdown, according to Bloomberg's reporting on investor chatrooms that lit up after the ban was announced.
Anthropic's move to invalidate unauthorized transfers is technically straightforward: the company's charter almost certainly includes a right of first refusal and a board-consent requirement for any transfer. Most venture-backed companies have these provisions. What is unusual is enforcing them aggressively at this scale, with this much secondary volume already in flight. The lawyers who drafted the ban, whose identities have not been disclosed, effectively told every SPV operator holding Anthropic shares that their claims might be unenforceable. The chill was immediate. One investor chatroom participant asked, "Are we screwed?" according to Bloomberg's account.
The crackdown serves a dual purpose. First, it allows Anthropic to present a clean, auditable cap table to the SEC without hundreds of SPVs whose beneficial owners may be unidentifiable. Second, and more tactically, it prevents price discovery from happening in the secondary market before the company's bankers at what are widely expected to be Goldman Sachs and Morgan Stanley have a chance to set the IPO range. If secondary trades had already established a $1.1 trillion clearing price, a $960 billion primary round four days before an S-1 looks like either a bargain for the Series H lead or a signal that the secondary market was running too hot.
The Three-Way Race Reshapes the Entire Pipeline
Anthropic is not alone. OpenAI filed its own confidential S-1 earlier in the spring, according to the Times of India, and has been valued at approximately $852 billion in its most recent private rounds. Meanwhile, SpaceX filed IPO paperwork targeting a $1.75 trillion valuation and a $75 billion raise, Reuters reported in April. The combined market capitalization of the three companies, if they price at their last private valuations, would exceed $3.5 trillion, making 2026 the largest year for U.S. IPO proceeds in history by a factor of at least two, as Seeking Alpha summarized in early June.
For companies still raising Series A through Series C rounds in AI and infrastructure, the implications are immediate and uncomfortable. Every institutional LP with a meaningful allocation to venture capital is now asking the same question: if I can buy Anthropic at IPO in three to six months, why should I commit to a blind-pool fund that might take seven years to return capital? The reallocation of LP dollars toward direct and co-investment opportunities around the mega-IPOs is already compressing the fundraising environment for emerging managers and earlier-stage funds.
April 2026 was the third-largest month for global venture funding in a year, with $56 billion deployed, Crunchbase News reported. But the headline number conceals a stark concentration: a handful of mega-rounds, including Anthropic's Series H and a reported funding round for Jeff Bezos's Project Prometheus, accounted for the majority of the total. The median round size for Series A deals in AI actually declined slightly in the first quarter, according to data from PitchBook, even as the mean was pulled upward by outlier deals.
Vast Data, the AI infrastructure company, closed a $1 billion Series F at a $30 billion valuation in April, with participation from Nvidia, Fidelity, Drive Capital, and Access Industries, CNBC reported. ScaleOps, a Kubernetes efficiency startup, raised $130 million in a Series C in March, TechCrunch noted, capitalizing on the brutal reality that GPU clusters sit idle far more than anyone in the industry likes to admit. These rounds are substantial, but they are dwarfed by the capital flowing into the foundational-model companies at the top of the stack.
The dynamic creates an hourglass shape in the AI funding market. At the top, the model builders, Anthropic, OpenAI, and the large cloud providers, absorb hundreds of billions of dollars. At the bottom, a long tail of application-layer startups raise seed and Series A rounds on the promise that someone else's model will do the heavy lifting. The mid-tier, the Series B and C companies building actual infrastructure, is where the pressure is most acute, because those rounds are too large for angels and too small for the sovereign wealth funds writing $5 billion checks into the Series H.
The Retail Spigot Opens, With Mixed Results
While institutional capital concentrates at the top, a parallel retail channel has opened. Genius Group, a publicly traded company, announced in early June that it had completed its first AI Treasury investments, deploying capital with approximately 16 percent exposure to Anthropic, 11 percent to SpaceX, and 7 percent to OpenAI through what it described as a disciplined dollar-cost averaging strategy. The announcement, issued via Markets Insider, is best understood as a marketing document, but it reflects a genuine trend: smaller public companies and even retail investors are finding ways to buy synthetic exposure to pre-IPO AI names.
Binance took the concept further in late May, launching perpetual futures contracts that allow traders to speculate on the anticipated valuation of SpaceX before the company goes public, CoinDesk reported. The contracts do not confer any ownership interest in SpaceX shares. They are a pure derivatives play, and they introduce a new layer of price discovery that operates entirely outside the SEC's purview. For a company on the cusp of an IPO, having a futures curve that implies a $2 trillion valuation when the last primary round was $1.75 trillion is not necessarily helpful. It creates expectations that the bankers underwriting the deal must either meet or explain away.
The USA Today press release from Black Titan Corporation in mid-May framed this convergence as the "retailization" of primary equity markets, a structural pivot driven by exchange-led pre-IPO products and the rise of agentic finance, the use of AI agents to autonomously settle credit and execute trades. The framing is promotional, but the underlying observation is accurate: the line between private and public markets, already blurred by the rise of secondary platforms, is now being erased by derivatives, tokenized claims, and AI-driven trading infrastructure that does not care about the distinction.
It may be a while because there are things we want to do that are likely easier as a private company., OpenAI, in a statement regarding its confidential IPO filing, as reported by MarketWatch
OpenAI's statement, carried by MarketWatch, is the kind of line that corporate communications teams draft when they want to file an S-1 without signaling urgency. But the market can read a calendar. Anthropic filed first. OpenAI, which had a multi-year head start and a far more recognizable consumer brand in ChatGPT, is now playing catch-up in the public-offering timeline. The Irish Times noted that OpenAI's filing came as rivals raced to market, a framing that implicitly acknowledges what the company's own statement tries to downplay.
The question hanging over all three filings is whether the public markets will validate the private valuations. Anthropic's $960 billion post-money Series H implies a revenue multiple that cannot be calculated because the company has not disclosed its revenue. Tokenist published a comparative analysis asking directly whether the valuation represents a bubble. The piece noted that Anthropic's draft S-1 will remain confidential for months, giving the SEC time to review and the company time to prepare its narrative before financials become public. That confidential period is the most important information asymmetry in the market right now.
For the venture capitalists who backed Anthropic's earlier rounds, the Series H and the imminent IPO represent a paper windfall of staggering proportions. The Series B investors from 2022, who bought in at a valuation of roughly $4 billion, are sitting on a mark-up of approximately 240x on paper. The Series C and D investors from 2023, who invested at valuations between $15 billion and $18 billion, are looking at roughly 50x. But those returns are not realized. The IPO will include a standard 180-day lockup, and the question of who gets to sell first, and at what price, is the one that the S-1, when it becomes public, will answer.
The participation cap, the limit on how much a single investor can buy at the IPO price, is the detail that every institutional allocator is waiting to see. If the lead underwriters allocate 60 percent of the offering to a handful of cornerstone investors, as happened with several large tech IPOs in the 2020-2021 cycle, the retail and smaller institutional buyers who have been buying SPV interests on Hiive and Linqto will find themselves locked out of the primary offering entirely. Their only path to liquidity will be the secondary market, where they will be selling to the same institutions that got the allocation they wanted.
SpaceX introduces a different set of variables. The company's $1.75 trillion target valuation, analyzed in detail by The Motley Fool in late April, depends heavily on the market's willingness to value Starlink's recurring revenue stream alongside the more speculative Starship launch business. Starlink is the cash-flow engine; Starship is the option value. The question for the IPO roadshow is whether institutional investors will apply a telecom multiple to Starlink and a deep-tech multiple to Starship, or whether they will blend the two into a single, lower number. The answer will determine whether the $75 billion raise prices at the top or the bottom of the range.
For earlier-stage AI and infrastructure companies, the most important number is not the IPO price of Anthropic or SpaceX. It is the post-IPO trading performance six months after the lockup expires. If the stocks trade down 30 percent in the first year, the entire private-market pricing edifice, from Series A through pre-IPO, will be recalibrated downward. Late-stage investors who paid $960 billion for Anthropic will be underwater, and the mark-to-model valuations that venture funds have been reporting to their LPs will face a reckoning. The Series A startups raising today are pricing their rounds on the assumption that the public comps will hold. That assumption has not been tested in the public markets for any AI foundational-model company, ever.
The next milestone to watch is the public release of Anthropic's S-1, which will disclose revenue, operating loss, customer concentration, and the specific risk factors the company's lawyers consider material. The filing will also reveal whether Anthropic has any take-private protections in place, a dual-class share structure, or any other governance provision that would allow the Amodeis and the board to retain control after the IPO. Those details, not the headline valuation, will determine whether the four-day dash from Series H to S-1 was a disciplined execution of a long-planned strategy or a scramble to get out ahead of a market that may already be turning.